The key to any fight is a strong ally
Adaptiiv fights for you in the battle against cancer. Our advanced software solution enables the creation of customized 3D personal medical devices, effectively improving treatment outcomes and patient experience.
Our patients define our success
Our personalized approach is developed entirely with you in mind. Your personal device is custom fitted designed to improve treatment accuracy.
We eliminate ill-fitting devices and believe patient outcomes are the only true measure of whether we succeed or fail. It's all about you – just like it should be.
How Adaptiiv works with cancer centers
Above all else, we care about delivering the best results to patients (and we know you do too). We reimagine conventional technologies to be more effective and efficient with our advanced algorithms, enabling your team to deliver personalized healthcare and precise treatments like never before.
We provide measurable ROI at all levels of care including Radiation Oncologists, Medical Physicists, Radiation Therapists, Dosimetrists, and even Administrators.
Our solutions at work
It's Personal
Adaptiiv's treatment method improves the patient experience. No more wet gauze, wax moulds or tape. A custom, patient-specific bolus is the most comfortable and accurate in the field that fits like a second skin.
Cost Effective
Do away with manual fabrication and countless hours of tedious design. Cancer centers using our automated solution save time and reduce their dependency on skilled staff.
Fully Integrated
We work seamlessly with your treatment planning system (TPS) via DICOM so clinicians can review bolus designs for fit and dose conformity prior to the creation of the custom device in-house.
Our organizational partners
Our patients drive our mission
Ciaran Malone, Medical Physisist, St. Luke's Radiation Oncology Network, Dublin, Ireland
3D Bolus has enabled us to confidently tackle situations where we would normally struggle to apply bolus. The benefit has already been seen in setup times, comfort and reproducibility. The ability to print the precise bolus required for electrons or photons is a powerful tool in an RT department.
Nova Scotia Health Authority
We 3D printed, then scanned the bolus on the patient. The bolus fit very well and the dosimetry is excellent, especially with regard to 90% dose conformity. All are pleased – including our Radiation Oncologist, Medical Physicist and therapists involved. A plan like this wouldn’t be possible any other way.
3D Bolus Client
Calculating the thickness of bolus and converting them into a printable 3D model is technically challenging. The 3D Bolus solution is well developed and is expected to work very well in conjunction with our planning system.
Chief Medical Physicist
We have the opportunity to become the UK leading centre in 3D printing for radiotherapy applications and to be a key research partner for 3D Bolus
Previous
Next
In The News
Adaptiiv Receives FDA 510(k) Clearance to Market 3D Bolus Software
HALIFAX, July 18, 2018 /CNW/ – Adaptiiv, an innovative medical technology company announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market 3D Bolus Software, an advanced software solution that enables the creation of customized personal medical devices using 3D printing, used primarily in the treatment of cancer. […]
CIVCO Radiotherapy & Adaptiiv Join Forces to Expand 3D Bolus for Radiotherapy
We are excited to be teaming up with CIVCO, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions. This initiative marks a milestone for Adaptiiv in improving patient outcomes in radiation therapy worldwide. Read more on our collaboration with CIVCO.
3D Bolus is now Adaptiiv
From the moment we were founded, we had big aspirations in mind – to be the definitive technology platform that could create transformational solutions and deliver life-changing outcomes for patients all over the world. The name 3D Bolus initially encapsulated everything we were at the very beginning. Boluses have long been a weak link in […]